Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Change in Accured Expenses (2016 - 2025)

cbdMD (YCBD) has disclosed Change in Accured Expenses for 10 consecutive years, with -$276942.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 16.97% to -$276942.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$302055.0 through Dec 2025, up 79.91% year-over-year, with the annual reading at -$261883.0 for FY2025, 76.7% up from the prior year.
  • Change in Accured Expenses hit -$276942.0 in Q4 2025 for cbdMD, down from -$67251.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $763157.0 in Q2 2021 to a low of -$1.6 million in Q3 2024.
  • Historically, Change in Accured Expenses has averaged -$168466.0 across 5 years, with a median of -$53808.0 in 2025.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 1494.93% in 2023 and later soared 20577.44% in 2025.
  • Year by year, Change in Accured Expenses stood at -$127254.0 in 2021, then skyrocketed by 130.81% to $39204.0 in 2022, then surged by 262.95% to $142292.0 in 2023, then crashed by 266.4% to -$236770.0 in 2024, then decreased by 16.97% to -$276942.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for YCBD at -$276942.0 in Q4 2025, -$67251.0 in Q3 2025, and $82503.0 in Q2 2025.